Evidence map›Paper›PMID 35731354›Full record

ArticleInternational ophthalmology2022

Histological and molecular characterization of glaucoma model induced by one or two injections of microbeads to the anterior chamber of mice.

Alon Zahavi, Moran Friedman Gohas, Amir Sternfeld, Nesrin Daoud Zreiq, Orkun Muhsinoglu, Ron Ofri, Yaniv BarKana, Nitza Goldenberg-Cohen

Abstract read
PubMed Publisher
In one paragraph

Article in International ophthalmology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 1 country.

Alon Zahavi *Department of Ophthalmology, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel. alonzahavi@gmail.com.ORCID http://orcid.org/0000-0002-9451-5253
Moran Friedman GohasKrieger Eye Research Laboratory, Rappaport Faculty of Medicine, Technion, Haifa, Israel.
Amir SternfeldDepartment of Ophthalmology, Rabin Medical Center - Beilinson Hospital, Petach Tikva, Israel.
Nesrin Daoud ZreiqKrieger Eye Research Laboratory, Rappaport Faculty of Medicine, Technion, Haifa, Israel.
Orkun MuhsinogluKrieger Eye Research Laboratory, Rappaport Faculty of Medicine, Technion, Haifa, Israel.
Ron OfriKoret School of Veterinary Medicine, Hebrew University of Jerusalem, Rehovot, Israel.
Yaniv BarKanaThe Glaucoma Innovation & Research Lab, The Sam Rothberg Glaucoma Center, Sheba Medical Center, Tel Hashomer, Israel.
Nitza Goldenberg-CohenKrieger Eye Research Laboratory, Rappaport Faculty of Medicine, Technion, Haifa, Israel.
Tel Aviv University · ILHebrew University of Jerusalem · ILNazareth Hospital EMMS · ILSheba Medical Center · ILTechnion – Israel Institute of Technology · IL

Funding

CSRD VA 1
6 · The paper itself

Abstract

purposeTo characterize glaucoma-induced damage following injections of plastic microbeads into the anterior chamber of mice.

methodsMice were divided into three groups: a single plastic microbeads injection (n = 21); two consecutive plastic microbead injections to the right eye at 1-week intervals, 4 of which with two consecutive saline injections in the left eye (n = 15); and an additional control group of two consecutive saline injections at 1-week intervals (n = 6). Intraocular pressure (IOP) was measured weekly. Retinal thickness, ganglion cells (RGCs) and axonal loss, inflammatory and gliosis reactions were measured at week four. Molecular analysis using qRT-PCR in the microbeads injection groups focused on expression levels of inflammation and glaucoma-related genes.

resultsMean IOP following single injection at 4 weeks was significantly elevated compared to baseline in injected eyes (14.5 ± 3.3 mmHg vs. 11.1 ± 2.5 mmHg, respectively, p = 0.003) and not in fellow eyes (13.2 ± 2.9 mmHg vs. 12.2 ± 2.9, respectively, NS). Six (35.3%) bead-injected eyes had IOP ≥ 17 mmHg compared with 2 (11.8%) saline-injected control eyes. Retinal thickness in injected and fellow eyes was 193.7 ± 15.5 µm and 223.9 ± 15.5 µm, respectively (p = 0.03). RGC loss in injected and fellow eyes was 16.0 ± 0.5 and 17.6 ± 0.7 cells per 200 µm, respectively (p = 0.005). Retinal gliosis, axonal loss and inflammatory cell infiltration to the bead-injected eyes were noted. Molecular analysis following double injection showed STAT3 expression decreased in the glaucoma-induced optic nerves (0.69 ± 0.3 vs. 1.16 ± 0.3, p = 0.04), but increased in the glaucoma-induced retinae (p = 0.05) versus saline; retinal IL-1β decreased significantly (0.04 ± 0.04 vs. 0.36 ± 0.2, p = 0.02). TNF-α, NFkB and SOD-1 expression did not change.

conclusionOne/two injections of microbeads elevated IOP, with measurable neuronal damage. An inflammatory response was detected in the injured retina and optic nerve. The therapeutic significance of these findings should be explored.

Indexed as

GlaucomaRetinal Ganglion CellsAnimalsAnterior ChamberAxonsDisease Models, AnimalGliosisIntraocular PressureMiceMicrospheresPlasticsPlasticsGlaucomaIntraocular pressureMicrobeadsOptic nerve

Identifiers

PMID35731354
OpenAlexW4283313963

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.